Literature DB >> 21185405

The use and abuse of multiple outcomes in randomized controlled depression trials.

Kristin M Tyler1, Sharon-Lise T Normand, Nicholas J Horton.   

Abstract

OBJECTIVE: Multiple outcomes are commonly analyzed in randomized trials. Interpretation of the results of trials with many outcomes is not always straightforward. We characterize the prevalence and factors associated with multiple outcomes in reports of clinical trials of depression, methods used to account for these outcomes, and concordance between published analyses and original protocol specifications.
METHODS: A PubMed search for randomized controlled depression trials that included multiple outcomes published between January 2007 and October 2008 in 6 medical journals. Original study protocols were reviewed where available. Parallel data collection by 2 abstractors was used to determine trial registration information, the number of outcomes, and analytical method.
RESULTS: Of the 55 included trials, nearly half of the papers reported more than 1 primary outcome, while almost all (90.9%, n = 50) reported more than 2 combined primary or secondary outcomes. Relatively few of the studies (5.8%, n = 3) adjusted for multiple outcomes. While most studies had published protocols in clinical trial registries (76.4%, n = 42), many did not specify outcomes in the protocol (n = 11) and a number had discrepancies with the published report.
CONCLUSIONS: Multiple outcomes are prevalent in randomized controlled depression trials and appropriate statistical analyses to account for these methods are rarely used. Not all studies filed protocols, and there were discrepancies between these protocols and published reports. These issues complicate interpretability of trial results, and in some cases may lead to spurious conclusions. Promulgation of guidelines to improve analysis and reporting of multiple outcomes is warranted.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21185405      PMCID: PMC3071542          DOI: 10.1016/j.cct.2010.12.007

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  34 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D Altman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

2.  Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.

Authors:  Abdul J Sankoh; Ralph B D'Agostino; Mohammad F Huque
Journal:  Stat Med       Date:  2003-10-30       Impact factor: 2.373

3.  Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors:  Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

4.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

5.  The analysis of multiple endpoints in clinical trials.

Authors:  S J Pocock; N L Geller; A A Tsiatis
Journal:  Biometrics       Date:  1987-09       Impact factor: 2.571

6.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

7.  Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.

Authors:  Joseph F Goldberg; Roy H Perlis; S Nassir Ghaemi; Joseph R Calabrese; Charles L Bowden; Stephen Wisniewski; David J Miklowitz; Gary S Sachs; Michael E Thase
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

8.  Treatment of acute stress disorder: a randomized controlled trial.

Authors:  Richard A Bryant; Julie Mastrodomenico; Kim L Felmingham; Sally Hopwood; Lucy Kenny; Eva Kandris; Catherine Cahill; Mark Creamer
Journal:  Arch Gen Psychiatry       Date:  2008-06

9.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

10.  Statistical Approaches to Modeling Multiple Outcomes In Psychiatric Studies.

Authors:  Armando Teixeira-Pinto; Juned Siddique; Robert Gibbons; Sharon-Lise Normand
Journal:  Psychiatr Ann       Date:  2009-07-01
View more
  11 in total

1.  Weak outcome predictors of multimodal rehabilitation at one-year follow-up in patients with chronic pain-a practice based evidence study from two SQRP centres.

Authors:  Björn Gerdle; Peter Molander; Gunilla Stenberg; Britt-Marie Stålnacke; Paul Enthoven
Journal:  BMC Musculoskelet Disord       Date:  2016-11-25       Impact factor: 2.362

2.  Statistics in clinical research: Important considerations.

Authors:  Howard Barkan
Journal:  Ann Card Anaesth       Date:  2015 Jan-Mar

3.  Training, executive, attention and motor skills (TEAMS) training versus standard treatment for preschool children with attention deficit hyperactivity disorder: a randomised clinical trial.

Authors:  Helle Annette Vibholm; Jesper Pedersen; Erlend Faltinsen; Michael H Marcussen; Christian Gluud; Ole Jakob Storebø
Journal:  BMC Res Notes       Date:  2018-06-08

4.  Primary outcome reporting in adolescent depression clinical trials needs standardization.

Authors:  Andrea Monsour; Emma J Mew; Sagar Patel; Alyssandra Chee-A-Tow; Leena Saeed; Lucia Santos; Darren B Courtney; Priya N Watson; Suneeta Monga; Peter Szatmari; Martin Offringa; Nancy J Butcher
Journal:  BMC Med Res Methodol       Date:  2020-05-25       Impact factor: 4.615

5.  Moderate and Stable Pain Reductions as a Result of Interdisciplinary Pain Rehabilitation-A Cohort Study from the Swedish Quality Registry for Pain Rehabilitation (SQRP).

Authors:  Åsa Ringqvist; Elena Dragioti; Mathilda Björk; Britt Larsson; Björn Gerdle
Journal:  J Clin Med       Date:  2019-06-24       Impact factor: 4.241

6.  Effect of an internet- and app-based stress intervention compared to online psychoeducation in university students with depressive symptoms: Results of a randomized controlled trial.

Authors:  Mathias Harrer; Jennifer Apolinário-Hagen; Lara Fritsche; Christel Salewski; Anna-Carlotta Zarski; Dirk Lehr; Harald Baumeister; Pim Cuijpers; David Daniel Ebert
Journal:  Internet Interv       Date:  2021-02-24

Review 7.  The Use of Multiple Primary Outcomes in Randomized Controlled Trials of Chinese Herbal Medicine.

Authors:  Jing Hu; Shuo Feng; Xiaoli Zhang; Huina Zhang; Yanxiang Ha; Chongyang Wei; Xuejiao Wang; Rui Zhang; Xing Liao; Bo Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-21       Impact factor: 2.629

8.  An empirical investigation of the potential impact of selective inclusion of results in systematic reviews of interventions: study protocol.

Authors:  Matthew J Page; Joanne E McKenzie; Sally E Green; Andrew B Forbes
Journal:  Syst Rev       Date:  2013-04-10

9.  Beyond the Primary Endpoint Paradigm: A Test of Intervention Effect in HIV Behavioral Intervention Trials with Numerous Correlated Outcomes.

Authors:  Jessica M Harwood; Robert E Weiss; W Scott Comulada
Journal:  Prev Sci       Date:  2017-07

10.  Handling incomplete correlated continuous and binary outcomes in meta-analysis of individual participant data.

Authors:  Manuel Gomes; Laura Hatfield; Sharon-Lise Normand
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.